YUNNAN BAIYAO(000538)
Search documents
半年报汇总丨这家公司上半年净利润同比增超4100%
Di Yi Cai Jing· 2025-08-29 13:49
Growth - Huayin Power reported a net profit of 207 million yuan for the first half of the year, a year-on-year increase of 4146.80% [1] - Guotou Zhonglu achieved a net profit of 25.08 million yuan, up 2149.03% year-on-year [1] - Jianfeng Group's net profit reached 618 million yuan, reflecting a year-on-year growth of 1196.93% [1] - Haixiang New Materials reported a net profit of 64.95 million yuan, with a year-on-year increase of 1099.05% [1] - Shanshan Co. posted a net profit of 207 million yuan, up 1079.59% year-on-year [1] - Huaxia Airlines achieved a net profit of 251 million yuan, a year-on-year increase of 858.95% [1] - Haitan Ruisheng reported a net profit of 3.80 million yuan, reflecting a year-on-year growth of 813.65% [1] - Wentai Technology's net profit was 474 million yuan, up 237.36% year-on-year [1] - ST Yigou reported a net profit of 48.69 million yuan, a year-on-year increase of 230.03% [1] - Youyan New Materials achieved a net profit of 130 million yuan, reflecting a year-on-year growth of 218.47% [1] - Guotai Haitong reported a net profit of 15.737 billion yuan, up 213.74% year-on-year [1] - Batian Co. posted a net profit of 456 million yuan, reflecting a year-on-year increase of 203.71% [1] - Changjiang Securities achieved a net profit of 1.737 billion yuan, up 120.76% year-on-year [1] - China Shipbuilding reported a net profit of 2.946 billion yuan, reflecting a year-on-year growth of 108.59% [1] - Shenwan Hongyuan posted a net profit of 4.284 billion yuan, up 101.32% year-on-year [1] - Zhongwei Semiconductor reported a net profit of 86.47 million yuan, reflecting a year-on-year increase of 100.99% [1] - Lankai Technology achieved a net profit of 1.159 billion yuan, up 95.41% year-on-year [1] - CICC reported a net profit of 4.33 billion yuan, reflecting a year-on-year growth of 94.35% [1] - TCL Technology posted a net profit of 1.883 billion yuan, up 89.26% year-on-year [1] - Guoxin Securities achieved a net profit of 5.367 billion yuan, reflecting a year-on-year increase of 71% [1] - Haowei Group reported a net profit of 2.028 billion yuan, up 48.34% year-on-year [1] - GF Securities posted a net profit of 6.47 billion yuan, reflecting a year-on-year growth of 48.31% [1] - Huatai Securities achieved a net profit of 7.549 billion yuan, up 42.16% year-on-year [1] - Lingyi Manufacturing reported a net profit of 930 million yuan, reflecting a year-on-year increase of 35.94% [1] - Guoxuan High-Tech achieved a net profit of 367 million yuan, up 35.22% year-on-year [1] - Zoomlion reported a net profit of 2.765 billion yuan, reflecting a year-on-year growth of 20.84% [1] - Yunnan Baiyao posted a net profit of 3.633 billion yuan, up 13.93% year-on-year [1] - BYD achieved a net profit of 15.511 billion yuan, reflecting a year-on-year increase of 13.79% [1] Decline and Loss - Agricultural Bank reported a net profit of 139.51 billion yuan, a year-on-year increase of 2.7% [2] - Gujing Gongjiu achieved a net profit of 3.662 billion yuan, up 2.49% year-on-year [2] - Bank of Communications reported a net profit of 46.016 billion yuan, reflecting a year-on-year increase of 1.61% [2] - Postal Savings Bank achieved a net profit of 49.228 billion yuan, up 0.85% year-on-year [2] - China Rare Earth reported a net profit of 16.2 million yuan, turning from loss to profit [2] - New Hope achieved a net profit of 75.5 million yuan, turning from loss to profit [2] - BeiGene reported a net profit of 450 million yuan, turning from loss to profit [2] - Shenghe Resources achieved a net profit of 37.7 million yuan, turning from loss to profit [2] - China Great Wall reported a net profit of 13.8 million yuan, turning from loss to profit [2] - Tianqi Lithium reported a net profit of 8.441 million yuan, turning from loss to profit [2] - Yunda Holdings reported a net profit of 52.9 million yuan, a year-on-year decline of 49.19% [2] - Magmi Te reported a net profit of 17.4 million yuan, down 44.82% year-on-year [2] - Youa Holdings reported a net profit of 5.348 million yuan, down 45.61% year-on-year [2] - Yanzhou Coal reported a net profit of 4.652 billion yuan, down 38.53% year-on-year [2] - Changfei Optical Fiber reported a net profit of 296 million yuan, down 21.71% year-on-year [2] - Pianzaihuang reported a net profit of 1.442 billion yuan, down 16.22% year-on-year [2] - China Shenhua reported a net profit of 246.41 billion yuan, down 12% year-on-year [2] - China Railway reported a net profit of 118.27 billion yuan, down 17.17% year-on-year [2] - Luzhou Laojiao reported a net profit of 766.3 million yuan, down 4.54% year-on-year [2] - Industrial and Commercial Bank reported a net profit of 168.103 billion yuan, down 1.4% year-on-year [2] - China Construction Bank reported a net profit of 162.076 billion yuan, down 1.37% year-on-year [2] - Jingwang Electronics reported a net profit of 64.9 million yuan, down 1.06% year-on-year [2] - Bank of China reported a net profit of 117.591 billion yuan, down 0.85% year-on-year [2] - Beijing-Shanghai High-Speed Railway reported a net profit of 6.316 billion yuan, down 0.64% year-on-year [2] - Baike Biotechnology reported a net loss of 73.5734 million yuan, turning from profit to loss [2] - ST Xintong reported a net loss of 95.1607 million yuan, turning from profit to loss [2] - Gemdale Group reported a net loss of 3.701 billion yuan [2] - China Eastern Airlines reported a net loss of 1.431 billion yuan [2] Additional Losses - Garden Holdings reported a net loss of 74.4346 million yuan [3] - Wantong Development reported a net loss of 28.0411 million yuan [3]
云南白药(000538.SZ)发布上半年业绩,归母净利润36.33亿元,同比增长13.93%
智通财经网· 2025-08-29 13:41
智通财经APP讯,云南白药(000538.SZ)发布2025年半年度报告,报告期内,公司实现营业收入212.57亿 元,同比增长3.92%。实现归属于上市公司股东的净利润36.33亿元,同比增长13.93%。实现归属于上市 公司股东的扣除非经常性损益的净利润34.61亿元,同比增长10.40%。基本每股收益2.04元。 ...
云南白药:全产业链竞争力彰显,上半年净利润逆势双位数增长,拟大额分红18.18亿回报投资者
Mei Ri Jing Ji Xin Wen· 2025-08-29 12:54
Core Viewpoint - Yunnan Baiyao reported record high performance for the first half of 2025, with a net profit growth of double digits, and announced a special dividend plan [1] Financial Performance - Revenue for the first half of 2025 reached 21.257 billion yuan, a year-on-year increase of 3.92% [1] - Net profit attributable to shareholders was 3.633 billion yuan, up 13.93% year-on-year, marking a historical high for the period [1] - Non-recurring net profit was 3.461 billion yuan, a 10.40% increase year-on-year [1] - Basic earnings per share were 2.04 yuan, reflecting a 13.97% growth [1] - Operating cash flow net amount was 3.961 billion yuan, up 21.45% year-on-year [1] Business Strategy and Development - The company has implemented a new model for party building, enhancing cohesion and competitiveness, which supports high-quality development [2] - Yunnan Baiyao is focusing on optimizing resource allocation and improving management capabilities as part of its strategic planning for 2024-2028 [2] Industrial and Product Performance - The industrial segment's revenue accounted for 40.01% of total revenue, with an increase of 2.6 percentage points year-on-year, and an industrial revenue growth rate of 11.13% [3] - The pharmaceutical sector achieved a revenue of 4.751 billion yuan, growing by 10.8% year-on-year, with significant sales increases in various product lines [3] - The health products segment generated 3.442 billion yuan in revenue, a 9.46% increase, maintaining a leading market share in toothpaste [4] - The commercial segment reported a revenue of 12.164 billion yuan, with a net profit of 351 million yuan, reflecting a 17.75% increase [5] Innovation and R&D - Yunnan Baiyao is advancing its R&D efforts with a focus on both traditional Chinese medicine and innovative drugs, with several projects in various stages of clinical trials [8] - The company has adopted a precise R&D and transformation model for its seed industry, achieving significant growth in the number of shipments despite market price pressures [7] Digital Transformation - The company is enhancing its digital transformation through AI and data technologies, achieving over 1 billion yuan in online business transactions [10] - A fully automated settlement process has been established, significantly reducing paper usage and improving operational efficiency [10] Future Outlook - Yunnan Baiyao aims to leverage strategic mergers and acquisitions to achieve sustainable growth and enhance investor returns, aligning with national policies to improve the quality of traditional Chinese medicine [11]
云南白药:9月15日将召开2025年第一次临时股东大会
Zheng Quan Ri Bao Wang· 2025-08-29 12:50
证券日报网讯8月29日晚间,云南白药(000538)发布公告称,公司将于2025年9月15日召开2025年第一 次临时股东大会。本次股东大会将审议《关于2025年特别分红方案的议案》等多项议案。 ...
云南白药上半年净利36.33亿元,同比增长13.93%
Bei Jing Shang Bao· 2025-08-29 12:34
北京商报讯(记者丁宁)8月29日晚间,云南白药(000538)发布2025年半年报显示,公司上半年实现 营业收入212.57亿元,同比增长3.92%;归属净利润36.33亿元,同比增长13.93%。 同时,云南白药发布2025年特别分红方案显示,拟向全体股东每10股派发现金红利10.19元(含税)。 (文章来源:北京商报) ...
云南白药:8月28日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-29 11:24
每经头条(nbdtoutiao)——近120个品牌、1600辆车逐鹿西南!下半年国内首个A级车展开幕:新能 源"第三极"将改写车市格局 每经AI快讯,云南白药(SZ 000538,收盘价:57.58元)8月29日晚间发布公告称,公司第十届2025年 第五次董事会会议于2025年8月28日在公司总部会议室以现场结合通讯表决的方式召开。会议审议了 《关于2025年半年度报告及其摘要的议案》等文件。 2024年1至12月份,云南白药的营业收入构成为:商业销售占比63.63%,工业销售占比36.14%,其他业 务占比0.12%,技术开发服务占比0.07%,旅店饮食业占比0.04%。 截至发稿,云南白药市值为1027亿元。 (记者 张喜威) ...
云南白药: 关于2025年特别分红方案的公告
Zheng Quan Zhi Xing· 2025-08-29 11:12
Core Viewpoint - Yunnan Baiyao Group Co., Ltd. announced a special dividend plan for 2025, aiming to enhance shareholder value and boost investor confidence through increased dividend frequency and optimized distribution rhythm [2][6]. Special Dividend Plan - The company plans to distribute a cash dividend of 10.19 yuan (including tax) for every 10 shares held, totaling 1.818 billion yuan, which represents 50.05% of the net profit attributable to shareholders for the first half of 2025 [2][6]. - The total number of shares for the dividend calculation is based on the total share capital of 1,784,262,603 shares as of the end of the second quarter of 2025 [2]. Financial Performance - For the first half of 2025, the company reported a revenue increase of 3.92% year-on-year, with a net profit attributable to shareholders of 36.33 billion yuan, reflecting a year-on-year growth of 13.93% [2]. - The net profit after deducting non-recurring gains and losses was 34.61 billion yuan, showing a year-on-year increase of 10.40% [2]. Approval Process - The special dividend plan was reviewed and approved by the Audit Committee on August 26, 2025, and subsequently by the Independent Directors on August 27, 2025 [3]. - The Board of Directors approved the plan on August 28, 2025, and it will be submitted for consideration at the first extraordinary general meeting of shareholders in 2025 [3][6]. Compliance and Legitimacy - The special dividend plan complies with relevant accounting standards and policies, aligning with the company's current development stage and financial status, thus benefiting the company and all shareholders [6].
云南白药(000538) - 半年度非经营性资金占用及其他关联资金往来情况汇总表
2025-08-29 11:11
金额单位:人民币万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的关 | 上市公司核算的会计 | 2025年初占用 | 2025年1-6月占用累计 | 2025年1-6月占用 | 2025年1-6月偿还 | 其他,如汇兑 | 2025年6月30日 | 占用形成原 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 联关系 | 科目 | 资金余额 | 发生金额(不含利 息) | 资金的利息(如 有) | 累计发生额 | 损益的影响 | 占用资金余额 | 因 | | 现大股东及其附属企业 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | | | 小 计 | —— | —— | —— | | | | | | | —— —— | | 前大股东及其附属企业 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | 无 | | | 小 计 | —— | —— | —— | | | | | | | —— —— | | 总 计 | —— | —— | —— | ...
云南白药(000538) - 关于召开2025年第一次临时股东大会的通知
2025-08-29 11:10
一、召开会议基本情况 (一)股东大会届次:2025 年第一次临时股东大会。 (二)召集人:公司第十届董事会。经公司第十届董事会 2025 年第 五次会议审议通过,决定召开 2025 年第一次临时股东大会。 股票代码:000538 股票简称:云南白药 公告编号:2025-30 云南白药集团股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没 有虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司(以下简称"公司")第十届董事会 2025 年第五次会议审议通过,决定于 2025 年 9 月 15 日召开 2025 年第一次临 时股东大会。现将本次股东大会相关事项通知如下: 2、通过深圳证券交易所互联网投票系统投票的时间为 2025 年 9 月 15 日 9:15-15:00。 (五)会议召开方式:本次股东大会以现场表决和网络投票相结合的 方式召开。公司将通过深圳证券交易所交易系统和互联网投票系统 1 / 7 (http://wltp.cninfo.com.cn)向公司股东提供网络形式的投票平台,公司股 东可以在规定的网络投票时间内通过上述 ...
云南白药(000538) - 半年报监事会决议公告
2025-08-29 11:09
股票代码:000538 股票简称:云南白药 公告编号:2025-27 云南白药集团股份有限公司 第十届监事会 2025 年第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司(以下简称"公司")第十届监事会 2025 年第三次会议(以下简称"会议")于 2025 年 8 月 28 日在公司总部会议 室以现场会议的方式召开,本次会议通知于 2025 年 8 月 18 日以书面、邮 件方式发出,应出席监事 3 名,实际出席监事 3 名。会议的召集、召开程 序符合《中华人民共和国公司法》(以下简称"《公司法》")及《公司 章程》的相关规定,会议合法有效。会议由监事会副主席戴普军先生主持, 与会监事充分讨论,审议通过了以下议案并形成如下决议: 一、审议通过《关于 2025 年半年度报告及其摘要的议案》 1、公司 2025 年半年度报告的编制和审议程序符合《公司法》《证券 法》《公司章程》等有关法律法规及公司规章制度的规定; 为进一步落实《国务院关于加强监管防范风险推动资本市场高质量发 展的若干意见》(国发〔2024〕10 号)及 ...